Skip to Content
Ronald V. Keech, MD, Associate Professor in Ophthalmic GeneticsDirector, Pediatric Electroretinogram ServiceAssociate Professor of Ophthalmology and Visual SciencesAssociate Professor of
Office: 11290-C PFPIowa City, IA 52242
Lab: 4111 MERFIowa City, IA 52242
Email: email@example.comWeb: Watch profile videoWeb: Dr Drack's Lab site (patient and research information)
BS, Biology / Philosophy, University of ScrantonMD, Medicine, The Pennsylvania State University College of Medicine
Fellowship, ITT International Fellow, Immunology, Det Norske Radiumhospitalet, University of OsloInternship, Transitional Internship, Georgetown University Medical CenterFellowship, Ophthalmic Genetics, Wilmer Institute, Johns Hopkins UniversityResidency, Ophthalmology, Georgetown University Medical CenterFellowship, Pediatric Ophthalmology and Strabismus, University of Iowa, Department of OphthalmologyFellowship, Molecular Ophthalmic Genetics, University of Iowa
Medical License, Iowa Board of MedicineMedical License (inactive), Colorado Board of Medical ExaminersMedical License (inactive), Georgia Composite Medical BoardABO Certification, American Board of OphthalmologyNBME Diplomate, National Board of Medical Examiners
Interdisciplinary Graduate Program in GeneticsInterdisciplinary Graduate Program in Neuroscience
Arlene V. Drack, M.D. is a clinician scientist specializing in juvenile inherited eye diseases. She is the inaugural Ronald V. Keech Associate Professor in Pediatric Ophthalmic Genetics at the University of Iowa Department of Ophthalmology and Visual Sciences. Her research focuses on inherited eye diseases that affect children, particularly in the development of novel treatments. She is experienced in subretinal injection of molecules to treat mouse models of retinal degeneration, as well as participating in human trials for retinal disorders. She co-directs both the clinical and rodent electroretinogram services at the University of Iowa. Her clinical practice includes the full scope of pediatric ophthalmology and strabismus, in addition to running specialized genetic eye disease clinics.
John and Marcia Carver Nonprofit Genetic Testing LaboratoryStephen A. Wynn Institute for Vision Research
Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration..
Human gene therapy.
2016 July 11.
Cataract and glaucoma development in juvenile neuronal ceroid lipofuscinosis (Batten disease).
Complement activation and choriocapillaris loss in early AMD: Implications for pathophysiology and therapy.
Prog Retin Eye Res.
Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases.
Prog Retin Eye Res.
Vitritis in pediatric genetic retinal disorders.
BBS mutations modify phenotypic expression of CEP290-related ciliopathies.
Hum Mol Genet.
Cadherin 5 is Regulated by Corticosteroids and Associated with Central Serous Chorioretinopathy.
Cataract and Glaucoma Development in Juvenile Neuronal Ceroid Lipofuscinosis (Batten Disease).
Transcriptomic analysis across nasal, temporal, and macular regions of human neural retina and RPE/choroid by RNA-Seq.
Exp Eye Res.
Visual Acuity Changes in Patients With Leber Congenital Amaurosis and Mutations in CEP290..
JAMA Ophthalmol. .
2013 February 1. 131(2):178-82.
Date Last Modified: 09/06/2016 -
Copyright © 2015 The University of Iowa. All Rights Reserved.